Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple muscle exercise improve erectile function in men with low testosterone?

NCT ID NCT07687173

Disease control Sponsor: Poznan University of Physical Education Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests whether pelvic floor muscle training (PFMT) with a handheld biofeedback device can improve erectile function and sexual quality of life in men with functional hypogonadism (low testosterone) and erectile dysfunction. Participants are randomly assigned to PFMT with biofeedback, PFMT alone, or a control group. The trial measures changes in pelvic floor muscle strength, endurance, and erectile performance over 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Pelvic floor muscle training with handheld biofeedback device
What this could lead to
If effective, this approach could offer a non-drug, non-surgical way to improve erectile function and sexual quality of life in men with low testosterone.
What could go wrong
This is a relatively small, early-stage trial. The training requires daily effort, and results may vary. The biofeedback device may not provide additional benefit over standard exercises.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * diagnosed functional hypogonadism * diagnosed erectile disorders * no diagnosed neurological disorders in pelvic floor area * no surgical interventions in pelvic floor area * no cancer in its active phase * ability to give individual consent * consent of participation and following the protocol Exclusion Criteria: * severe cardiovascular diseases * cancer treatment in progress * scars and surgical interventions in the pelvic floor area * neurological disorders affecting to pelvic floor * scars that makes measurements impossible * other treatment that affects sexual field similar to this protocol * participation in other rehabilitation programme less than 6 months before this programme * severe neurological disorders that makes cooperation impossible * no technical possibilities to do the measures to the patient * disagreement to participate in the programme

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Biofeedback training are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Beckwith-Wiedemann syndrome erectile dysfunction hypogonadism hypogonadism, male hypogonadotropic hypogonadism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Biofeedback training EMG Erectile disfunction Functional hypogonadism Hypogonadal males Pelvic floor muscle exercise

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Poznań University of Physical Education

    Poznan, Wielkopolska, 61-871, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.